The tryptic peptides of synaptotagmin-1 assays also correlated with each other in all investigated groups (controls, MCI due to Alzheimer’s disease, and dementia due to Alzheimer’s disease) in the respective sample sets. Here, SYT1 is linked to Alzheimer disease.